Lenstec, Inc.
  • Home
  • About Us
    • Company History
    • Locations
    • Regulatory Registrations
  • Products
    • International >
      • Softec Series IOLs >
        • Softec HD >
          • Technical Specifications
          • Resources
          • Testimonials
        • Softec HDM >
          • Technical Specifications
        • Softec HD3
        • Softec I >
          • Technical Specifications
          • Resources
        • Softec HDY >
          • Technical Specifications
          • Resources
        • Softec HDO >
          • Technical Specifications
          • Resources
      • Softec HP1
      • ClearView3 >
        • Technical SpecificationsCV
        • ResourcesCV
      • Resources
      • Resources
      • SBL-3 >
        • SBL-3 Technical Specs
      • SBL-2 >
        • SBL-2 Technical Specs
      • Tetraflex HD >
        • Technical Specifications
        • Resources
      • PMMA Lenses
      • Surgical Knives
      • Capsular Tension Rings
      • Instruments/Delivery System >
        • Resources
    • U.S.A. >
      • Softec HD >
        • Technical Specifications
        • Resources
        • Testimonials
      • Softec HDO >
        • Technical Specifications
        • Resources
      • Softec HDM >
        • Technical Specifications
      • Softec I >
        • Technical Specifications
        • Resources
      • ClearView3 >
        • Technical SpecificationsCV
        • ResourcesCV
      • Instruments/Delivery System >
        • Resources
    • Instructions for Use
    • VideoTestimonials >
      • Tyson
      • Harvey
      • Desai
      • Woodcock
      • Wortz
      • Matossian
  • News
  • Customers
  • Contact Us

Dr. Ackerman Reeling in ClearView™️ 3 MIOL

9/22/2022

 
Picture
Picture
Picture
 Bo Ackerman. M.D. at Advanced Eye Center is reeling in next generation premium lens technology! Dr. Ackerman is the first surgeon in Georgia to implant the newly FDA approved ClearView™️ 3 Multifocal IOL. 🙌 Lenstec’s proprietary design provides near, intermediate and distance vision with much less halo and glare than older MIOLs on the market. Pictured with Dr. Ackerman are Lenstec’s Jeff Harris and Missy Mason. Congratulations Dr. Ackerman! 🎉
#eyecare #eyesurgeon #cataract #norings #clearview3 #nextgenerationtechnology

first ClearView™ 3 MIOL Implanted in New York!

9/21/2022

 
Picture
Picture
​Congratulations Dr. Satish Modi at Seeta Eye Center for implanting the first ClearView™ 3 MIOL in New York! The ClearView 3 is the next generation presbyopia correcting IOL, providing near, intermediate and distance vision without concentric rings, significantly reducing visual disturbances. Pictured with Dr. Modi is Lenstec’s Jim Woodward and Ashley Kennedy. Welcome to the ClearView 3 family Dr. Modi!

ClearView Multifocal implanted @ Dougherty Laser Vision

9/20/2022

 
​Congratulations to Paul Dougherty M.D. and his team at Daugherty Laser Vision for being the first to implant the ClearView™ 3 Multifocal IOL in California! Lenstec is looking forward to working closely with you to achieve our main goal of happy, satisfied patients.
Picture

Bret Fisher, M.D. of Eye Centers of North Florida, is the first surgeon in Panama City, FL to implant the ClearView™ 3 Multifocal

9/19/2022

 
Picture
Picture
Picture
Lenstec is proud to announce that Bret Fisher, M.D. of Eye Centers of North Florida, is the first surgeon in Panama City, FL to implant the ClearView™ 3 Multifocal IOL. The Lenstec ClearView 3 is a next generation Multifocal IOL that provides distance, intermediate and near visions. Welcome to the ClearView 3 family, Dr. Fisher! #clearview
#norings #cataractsurgery #lenstec

Dr. Loden implants ClearView IOL

9/15/2022

 
​Congratulations to James Loden, M.D. (Loden Vision Centers – Goodlettsville, TN) for being the first surgeon in Tennessee to implant Lenstec, Inc.’s newly approved ClearView™ 3 Multifocal IOL. The ClearView 3 has a proprietary next generation lens design that provides patients with near, intermediate and distance vision, with reports of much lower visual disturbances than traditional MIOLs with concentric rings. Over 93% of patients in the FDA clinical trial reported spectacle independence and over 90% achieved binocular visual acuities of 20/25 or better at all distances.

Dr. Loden served as a principal investigator in FDA clinical trials of the ClearView 3 MIOL. He noted that during the trial “patients reported high quality distance and near vision, without the headache of severe dysphotopsia issues, and we had no complaints with computer vision”.

Lenstec is proud to have a surgeon with Dr. Loden’s outstanding reputation and expertise using the ClearView 3 and to be the first in Tennessee to implant our presbyopia correcting lens. We look forward to continuing to work with him and his staff at Loden Vision Centers.
#lenstec #lodenvisioncenters #clearview #norings #cataractsurgery
Picture
Picture
Picture

    Archives

    March 2024
    January 2024
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    July 2021
    November 2020
    March 2020
    September 2019
    August 2019
    May 2019
    August 2018
    May 2018
    March 2018
    May 2017
    February 2017
    April 2016
    August 2015
    January 2015
    October 2014
    May 2014
    April 2014
    November 2013
    May 2013
    April 2013
    March 2012

    RSS Feed

World Headquarters

Lenstec, Inc.
1765 Commerce Ave. N.
St. Petersburg, FL 33716 USA
Tel: +1 727-571-2272
Fax: +1 727-571-1792


U.S. CUSTOMER SERVICE:
TEL: 1-866-536-7832
FAX: 1-866-536-3040

​Lenstec Barbados

Lenstec (Barbados) Inc.
Airport Commercial Centre
Pilgrim Road
Christ Church, Barbados BB17092
Tel: 246-420-6795
Fax: 246-420-6797


​

LENSTEC UK

LENSTEC (BARBADOS) INC.
LENSTEC HOUSE
UNIT 8, MARINER House
CALDER PARK
WAKEFIELD
West Yorkshire wf4 3fl
ENGLAND
​TEL: +44 (0)1924 382 678
FAX:+44 (0)1924 850 454
​

EUROPEAN REGIONAL OFFICE

TRENCIANSKA 47
821 09 BRATISLAVA
SLOVAK REPUBLIC

TEL: 00421905798760





​
​INDICATION 
The Lenstec Softec Aspheric Posterior Chamber Intraocular Lens is intended for the replacement of the human crystalline lens following phacoemulsification cataract removal in adults over the age of 21. The lens is indicated for capsular bag placement.
Please note that not all intraocular lenses are available in all countries.  Only the SoftecHD, SoftecHDO, SoftecHDM, SoftecI and ClearView 3 intraocular lenses are FDA approved.
CAUTION: Federal (U.S.) law restricts some of these devices to the sale by or on the order of a physician.
Lenstec, Inc. is an ISO 13485 company manufacturing CE Marked Products with additional registrations of several countries.
​DUNS: 807554100
© 2021 Lenstec, Inc. All Rights Reserved. Lenstec, Softec, Softec HD, Tetraflex, SBL-3, and the Softec HD logo are registered trademarks of Lenstec, Inc.